Trilogy Capital Inc. trimmed its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 91.8% during the second quarter, HoldingsChannel reports. The firm owned 833 shares of the medical research company’s stock after selling 9,302 shares during the quarter. Trilogy Capital Inc.’s holdings in Amgen were worth $302,000 as of its most recent […]

Ravenstone Capital Management Inc. lifted its holdings in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 14.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,555 shares of the business services provider’s stock after buying an additional 3,141 shares […]